Congress Asset Management CO Atri Cure, Inc. Transaction History

Congress Asset Management CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	BUY	$40.44 - $49.6 $430,645 - $528,190	10,649 Added 10.71%	110,094 $5.43 Million
Q1 2023 Apr 21, 2023	BUY	$35.87 - $47.22 $355,973 - $468,611	9,924 Added 11.09%	99,445 $4.12 Million
Q4 2022 Jan 18, 2023	BUY	$33.48 - $47.45 $24,072 - $34,116	719 Added 0.81%	89,521 $0
Q3 2022 Nov 08, 2022	BUY	$38.25 - $52.62 $1.2 Million - $1.66 Million	31,465 Added 54.88%	88,802 $3.47 Million
Q2 2022 Aug 02, 2022	BUY	$35.1 - $66.01 $32,432 - $60,993	924 Added 1.64%	57,337 $2.34 Million
Q1 2022 Apr 20, 2022	BUY	$57.43 - $71.39 $3.24 Million - $4.03 Million	56,413 New	56,413 $3.71 Million

212

49.7M

12K

7.2K

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.67B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

Get notified when there are updates to the investment portfolio of Congress Asset Management CO , based on Form 13F filings with the SEC.

Stay updated on Congress Asset Management CO with notifications on news.